RWS
KRYS icon

Retirement Wealth Solutions’s Krystal Biotech KRYS Stock Holding History

Retirement Wealth Solutions’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97K Hold
8
– – ﹤0.01% 443
2026
Q1 		$2.07K Buy
8
+1
+14% +$266 ﹤0.01% 493
2025
Q4 		$1.73K Buy
7
+5
+250% +$1.05K ﹤0.01% 486
2025
Q3 		$354 Buy
+2
New +$299 ﹤0.01% 729

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Retirement Wealth Solutions's KRYS Position: Q2 2026 in Review

Retirement Wealth Solutions held its Krystal Biotech (KRYS) position steady in Q2 2026 at 8 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

Retirement Wealth Solutions first reported a position in KRYS in Q3 2025 and has held it in 4 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Retirement Wealth Solutions held 8 shares of Krystal Biotech worth $2.97K as of Q2 2026.
  • Retirement Wealth Solutions left its Krystal Biotech share count unchanged in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #443 holding.
  • Retirement Wealth Solutions first reported a position in Krystal Biotech in Q3 2025 and has held it in 4 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.